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1,595 patients received DES. Patients were assigned to four groups according to the
quadrant values of admission HbA1c. The primary endpoint was composite of MACE
(all-cause death, ACS and revascularization). The mean follow-up duration was 4.5
years. As ﬁgured showed, the higher the HbA1c, the higher the rate of MACE and ASC
plus death (p<.0001, 0.002) in the BMS group. However, HbA1c showed no such
correlation with MACE and ACS plus death (p ¼ 0.20, 0.69) in the DES group. Multi-
variable Cox regression analysis showed that HbA1c was not associated with long-
term outcomes in DES.
CONCLUSIONS HbA1c has no impact on long-term outcomes of patients implanted
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BACKGROUND Drug-eluting balloons (DEB) have shown effectiveness in the treat-
ment of bare metal and drug-eluting stent in-stent restenosis (ISR). Preclinical in-
vestigations have suggested that coating technology is crucial for the efﬁcacy of DEB.
Aim of this study is to compare the antirestenotic efﬁcacy of two paclitaxel DEB with
different coatings in the treatment of ISR by means of a morphological and functional
assessment.
METHODS In a single center, prospective, non-randomized study, the shellac-pacli-
taxel coated DIOR (EuroCor GmbH, Bonn, Germany) and the urea-paclitaxel coated
IN.PACT Falcon (Medtronic Vascular Inc., Santa Rosa, CA, USA) were compared in the
setting of ISR. Besides quantitative angiography, fractional ﬂow reserve (FFR) and
optical coherence tomography (OCT) were performed at baseline, post-procedure and
6-months follow-up. Main endpoints of the analysis were QCA, FFR and OCT-based
parameters of restenosis.
RESULTS Forty-ﬁve patients were included, 20 (44%) received treatment with the
DIOR and 25 (56%) with the IN.PACT Falcon. Angiographic and device success were
100% and 90% for the DIOR, and 100% and 92% for the IN.PACT Falcon, respec-
tively. At 6-months follow-up, in-segment late lumen loss (-0.030.43 vs.
0.360.48 mm, p¼0.014) and diameter stenosis (30.716.2 vs. 41.322.6%, p¼0.083)
were lower for the IN.PACT Falcon. FFR distal of the stent was signiﬁcantly higher
in the IN.PACT Falcon group (0.920.07 vs. 0.840.13, p¼0.029) and in-stent FFR
gradient was lower (0.050.05 vs. 0.130.12, p¼0.002). Between postprocedure and
follow-up, a 16% decrease in neointimal volume was observed for the IN.PACT
Falcon, while a 30% increase was observed for the DIOR (p¼0.006). Target lesion
revascularization rate was 8% in the IN.PACT Falcon and 30% in the DIOR group
(p¼0.11).
CONCLUSIONS The IN.PACT Falcon DEB showed higher antirestenotic efﬁcacy than
the DIOR in the treatment of ISR, demonstrating that DEB with an excipient based
coating are not equally effective. Comparative assessment of DEB in the clinical
setting is warranted.CRT-169
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BACKGROUND Chronic alcohol consumption is known to be a risk factor of signiﬁcant
coronary artery disease (CAD). However, currently there is no available data with
larger study population regarding long-term clinical outcomes of CAS patients (pts)
with chronic alcohol consumption in real world clinical practice.
METHODS A total of 3,349 consecutive pts without signiﬁcant coronary artery disease
(CAD) underwent acetylcholine (Ach) provocation test between Nov. 2004 and May.
2014 and positive CAS pts were enrolled. Signiﬁcant CAS was deﬁned as > 70% of
narrowing by incremental intracoronary injection of 20, 50 and 100 mg into left cor-
onary artery. Patients were divided into two groups based on the presence of alcohol
consumption: the Alcoholic group (n¼1,189), the control group (n¼2,160). To adjust
potential confounders, a propensity score matched (PSM) analysis was performed
using the logistic regression model.
RESULTS After PSM analysis, 2 propensity-matched groups (877 pairs, n¼1,754, C-
statistic¼0.796) were generated and the baseline characteristics of the two groups
were balanced. At 5 years, there were similar incidence of individual hard endpoints
including mortality, myocardial infarction, revascularization and recurrent angina
requiring repeat coronary angiography between the two groups.
CONCLUSIONS Despite the expected endothelial dysfunction, chronic alcohol con-
sumption was not associated with worse clinical outcomes in CAS pts up to 5 years,
suggesting that the mechanisms and risk factors of CAS may be different from those of
atherosclerotic CAD.CRT-170
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BACKGROUND Ischemic heart diseases including stable angina & acute events,
represent a huge burden on both the individual & the society and represents an
important source of disability.
AIM We aimed to identify the effect of cardiac rehabilitation program (CRP) on the
ischemic burden in patients with ischemic heart disease (IHD) unsuitable for coronary
revascularization.
METHODS Forty patients with IHD who were unﬁt for coronary revascularization were
recruited. All patients were subjected to sophisticated CRP protocols, including patient








Yeducation, nutritional, medical, psychological and sexual counseling and group
smoking cessation. All patients participated in low intensity exercise program twice
weekly. The patient’s symptoms, vitals and medications were evaluated at each
visit and clinical and laboratory data, echocardiography and stress myocardial perfu-
sion imaging (SPECT) were evaluated before and 3 months after the end of the study.
RESULTS The mean age was 56.83.1 years and only 2 patients (5%) were females.
22(55%) patients were diabetic, 21 (53%) were hypertensive and 30 (75%) were
smokers. It was found that 3 months after completion of CRP, there was a signiﬁcant
decrease in BMI (30.32.9 vs. 31.21.9, p<0.001), and mean blood pressure (93.411
vs. 10510.6 mmHg, p<0.001). There was also a favorable effect on lipid proﬁle and a
signiﬁcant improvement of the functional capacity in terms of NYHA functional class
(2.10.62 vs. 1.40.6, p<0.001). Despite that wall motion score index did not
signiﬁcantly change after CRP, there was a strong trend towards a better ejection
fraction (53.77.8 vs. 54.56.3 %, p¼0.06) and signiﬁcant improvement of Canadian
cardiovascular class (1.420.6 vs. 1.950.5, p<0.001) post CRP. Importantly, the
difference between the SPECT-derived summed segmental scores at peak stress and
at rest (SDS) was signiﬁcantly lower after CRP (4.43 vs. 7.23, p<0.001).
CONCLUSION Participation in cardiac rehabilitation program improves ischemic
burden in patients with IHD who are unﬁt or not suitable for conventional cardiac
revascularization. In addition the decreased ischemic burden, functional capacity,
hemodynamic and metabolic proﬁles also improves for this group of patients and
thus, cardiac rehabilitation should be implemented for routine management of those
patients.
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BACKGROUND Coronary artery calciﬁcation (CAC) is an established risk factor for
poor cardiovascular clinical outcomes. This economic modeling analysis estimates
the incremental impact of CAC on medical care costs and patient mortality for de novo
percutaneous coronary intervention (PCI) patients in the 2012 cohort of the Medicare
elderly (>65) population.
METHODS The target study population is the Medicare elderly with atherosclerosis in
calendar year 2012 experiencing a new index event, deﬁned as a patient receiving a
coronary angiogram with no prior coronary revascularization in the preceding six
months. This aggregate burden of illness study is incidence-based, focusing on cost
and survival outcomes for an annual Medicare cohort based on the recently intro-
duced ICD9 code for CAC. The horizon of the cost analysis uses a one-year horizon,
and the survival analysis considers lost life years and their economic value. The
principal data sources for cost and survival analyses were Medicare’s Standard Ana-
lytic Files. Estimates of the degree of calciﬁcation and the incidence of MACE were
based on the HORIZONS-AMI/ACUITY elderly pooled sample.
RESULTS For calendar year 2012, an estimated 200,945 index (de novo) PCI pro-
cedures were performed in this cohort. An estimated 16,000 Medicare beneﬁciaries
(7.9%) were projected to have had severe CAC generating an additional cost in the
ﬁrst year following their PCI of $3,500, on average, or $56 million in total. In terms of
mortality, the model projects an additional 397 deaths would be attributable to severe
CAC in 2012, resulting in 3,770 lost life years, representing an estimated loss of about
$377 million, when valuing lost life years at $100,000 each. An estimated 63,000
patients had moderate CAC.
CONCLUSIONS These model-based CAC estimates, considering both moderate and
severe CAC patients, suggest an annual burden of illness approaching $1.3 billion in
this PCI cohort. The potential clinical and cost consequences of CAC warrant addi-
tional clinical and economic attention not only on PCI strategies for appropriate pa-





Is the Allen Test Necessary Before Transradial Artery Catheterization?
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of Cardiology, Sivas, TurkeyOBJECTIVE We investigated whether Allen test is necessary before transradial
approach.
BACKGROUND Transradial approach has been feasible and effective for cardiac and
other vascular interventions in recent years. Most operators use a modiﬁed Allen
test due to known collateral circulation in the hand; however, the deﬁnition of
abnormal Allen test is not consistent and necessity before radial cannulation is not
well deﬁned.
METHODS The study population consisted of 2650 patients who had been per-
formed cardiac catheterization or peripheral angiography (abdominal aortic, lower
extremity) via radial access between 2011 and 2013. All of the patients were retro-
spectively investigated. Sixty ﬁve patients (Group A) had abnormal Allen test before
transradial catheterization. One hundred and thirty age, sex and risk factors
matched patients who had normal Allen test before transradial catheterization was
taken as control group (Group B). No other test was used to assess collateral cir-
culation in the hand. Standard cannulation techniques were used. One month after
the procedure, all of the patients were performed Doppler ultrasonography for
radial artery ﬂow.
RESULTS Procedural success was similar between both groups (96.9% and 98.5%,
p¼0.367), and no major complication (subacute or delayed occlusion, spasm, hema-
toma, compartment syndrome, perforation/laceration/dissection, avulsion, AV
ﬁstula, pseudoaneurysm, digital ischemia, transient vocal cord paralysis) was
developed in both groups during and after the procedure. Minor complications
(subcutaneous edema, paresthesia, and ecchymosis) were developed in three patients
in group A. However, none of them required surgical intervention. Doppler ultraso-
nography showed normal radial ﬂow patterns in both study groups at one month
post-procedural follow-up.
CONCLUSION Allen test may not be necessary before transradial access.CRT-174
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BACKGROUND Transradial access for coronary angiography is widely used because of
the low risk of complications and faster ambulation times for patients. Ulnar artery
can also be easily accessed for coronary angiography. We compared the safety and
efﬁcacy of this approach in this meta-analysis.
METHODS PubMed, EBSCO and Google Scholar databases were queried for studies on
transradial and transulnar access. Efﬁcacy and adverse events for both these routes were
then extracted and analyzed with Revman 5.2 software using random effects model.
RESULTS A total of 7 studies with 13,285 patients were included in this meta-
analysis. There was a high percentage of successful radial artery access with a very
low risk of crossover to alternate site compared to ulnar artery access (OR 0.32, 95%
CI 0.12-0.91). This was driven by a high crossover rate in the ulnar group in one
particular study. The number of attempts needed to gain successful access was very
similar between the two groups (mean difference ¼ -0.18, 95% CI -0.27-0.09). The
incidence of complications such as hematomas (OR 0.81, 95% CI 0.41-1.61), arterial
spasm (OR 1.21, 95% CI, 0.47-3.14), arterial occlusion (OR 0.93, 95% CI 0.68-1.28)
and major adverse cardiovascular events (OR 1.17, 95% CI 0.73-1.86) were similar in
both groups.
CONCLUSION There was a lower incidence of crossover with the radial access compared
to ulnar. However, the complication rates were similar between the two groups.
